{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:02:34Z","timestamp":1792180954371,"version":"4.4.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2018,1,23]]},"abstract":"<jats:sec xml:lang=\"en\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      Uncertainties remain about the current risk of myocardial infarction (\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      ) after ischemic stroke or transient ischemic attack.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Methods and Results<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      We undertook a systematic review to estimate the long\u2010term risk of\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      , compared to recurrent stroke, with temporal trends in ischemic stroke\/transient ischemic attack patients. Annual risks and 95% confidence intervals (95%\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">CI<\/jats:styled-content>\n                      ) of\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      and recurrent stroke were estimated using random\u2010effect meta\u2010analyses. We calculated incidence ratios of\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      \/recurrent stroke, for fatal and nonfatal events, using similar analyses. Rate ratios for\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      in patients with potential risk factors compared to those without were calculated using Poisson regression.\n                    <\/jats:p>\n                    <jats:p xml:lang=\"en\">\n                      A total of 58 studies (131\u00a0299 patients) with a mean (range) follow\u2010up of 3.5 (1.0\u201010.0) years were included. The risk of\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      was 1.67%\/y (95%\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">CI<\/jats:styled-content>\n                      1.36\u20101.98,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>het<\/jats:sub>\n                      &lt;0.001 for heterogeneity) and decreased over time (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>int<\/jats:sub>\n                      =0.021); 96% of the heterogeneity between studies was explained by study design, study period, follow\u2010up duration, mean age, proportion of patients on antithrombotic therapy, and incident versus combined ischemic stroke\/transient ischemic attack. The risk of recurrent stroke was 4.26%\/y (95%\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">CI<\/jats:styled-content>\n                      3.43\u20105.09,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>het<\/jats:sub>\n                      &lt;0.001), with no change over time (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>int<\/jats:sub>\n                      =0.63). The risk of fatal\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      was half the risk of recurrent strokes ending in fatality (incidence ratio=0.51, 95%\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">CI<\/jats:styled-content>\n                      0.14\u20100.89,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>het<\/jats:sub>\n                      =0.58). The risk of nonfatal\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      was 75% smaller than the risk of recurrent nonfatal stroke (incidence ratio=0.25, 95%\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">CI<\/jats:styled-content>\n                      0.02\u20100.50,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      <jats:sub>het<\/jats:sub>\n                      =0.68). Male sex, hypertension, coronary and peripheral artery diseases were associated with a doubled risk of\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec xml:lang=\"en\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p xml:lang=\"en\">\n                      After ischemic stroke\/transient ischemic attack, the risk of\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      is currently &lt;2%\/y, and recurrent stroke is a more common cause of death than\n                      <jats:styled-content style=\"fixed-case\" toggle=\"no\">MI<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/jaha.117.007267","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T20:20:15Z","timestamp":1516306815000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":151,"title":["Long\u2010Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta\u2010Analysis"],"prefix":"10.1161","volume":"7","author":[{"given":"Marion","family":"Boulanger","sequence":"first","affiliation":[{"name":"Normandie Universit\u00e9 UNICAEN, Inserm U1237","place":["Caen, France"]},{"name":"CHU Caen","place":["Caen, France"]},{"name":"University of Oxford","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"B\u00e9jot","sequence":"additional","affiliation":[{"name":"University of Burgundy","place":["Dijon, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Rothwell","sequence":"additional","affiliation":[{"name":"University of Oxford","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Touz\u00e9","sequence":"additional","affiliation":[{"name":"Normandie Universit\u00e9 UNICAEN, Inserm U1237","place":["Caen, France"]},{"name":"CHU Caen","place":["Caen, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0895-4356(02)00572-3","article-title":"Stroke subtype and mortality. A follow\u2010up study in 998 patients with a first cerebral infarct","volume":"56","author":"de Jong G","year":"2003","unstructured":"de Jong G, van Raak L, Kessels F, Lodder J. Stroke subtype and mortality. A follow\u2010up study in 998 patients with a first cerebral infarct. J Clin Epidemiol. 2003;56:262\u2013268.","journal-title":"J Clin Epidemiol"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jnnp.74.5.577","article-title":"Long term risks of stroke, myocardial infarction, and vascular death in \u201clow risk\u201d patients with a non\u2010recent transient ischaemic attack","volume":"74","author":"Clark TG","year":"2003","unstructured":"Clark TG, Murphy MF, Rothwell PM. Long term risks of stroke, myocardial infarction, and vascular death in \u201clow risk\u201d patients with a non\u2010recent transient ischaemic attack. J Neurol Neurosurg Psychiatry. 2003;74:577\u2013580.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(05)66734-7","article-title":"Long\u2010term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study","volume":"365","author":"van Wijk I","year":"2005","unstructured":"van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A; Li LACsg . Long\u2010term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet. 2005;365:2098\u20132104.","journal-title":"Lancet"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/STROKEAHA.113.003414","article-title":"Predicting asymptomatic coronary artery disease in patients with ischemic stroke and transient ischemic attack: the precoris score","volume":"45","author":"Calvet D","year":"2014","unstructured":"Calvet D, Song D, Yoo J, Turc G, Sablayrolles JL, Choi BW, Heo JH, Mas JL. Predicting asymptomatic coronary artery disease in patients with ischemic stroke and transient ischemic attack: the precoris score. Stroke. 2014;45:82\u201386.","journal-title":"Stroke"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/01.STR.0000190118.02275.33","article-title":"Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta\u2010analysis","volume":"36","author":"Touze E","year":"2005","unstructured":"Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta\u2010analysis. Stroke. 2005;36:2748\u20132755.","journal-title":"Stroke"},{"issue":"2","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.hjr.0000277983.23934.c9","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)","volume":"14","author":"Graham I","year":"2007","unstructured":"Graham I, Atar D, Borch\u2010Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann\u2010Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans\u2010Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck\u2010Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen mL, Mancia G, Manolis AJ, Orth\u2010Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC), European Association for Cardiovascular Prevention and Rehabilitation (EACPR), Council on Cardiovascular Nursing, European Association for Study of Diabetes (EASD), International Diabetes Federation Europe (IDF\u2010Europe), European Stroke Initiative (EUSI), Society of Behavioural Medicine (ISBM), European Society of Hypertension (ESH), WONCA Europe (European Society of General Practice\/Family Medicine), European Heart Network (EHN), European Atherosclerosis Society (EAS) . European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14(suppl 2):S1\u2013S113.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee","volume":"106","author":"Pearson TA","year":"2002","unstructured":"Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388\u2013391.","journal-title":"Circulation"},{"key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/STR.0b013e31825bcdac","article-title":"Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Lackland DT","year":"2012","unstructured":"Lackland DT, Elkind MS, D'Agostino R Sr, Dhamoon MS, Goff DC Jr, Higashida RT, McClure LA, Mitchell PH, Sacco RL, Sila CA, Smith SC Jr, Tanne D, Tirschwell DL, Touze E, Wechsler LR; American Heart Association Stroke C, Council on E, Prevention, Council on Cardiovascular R, Intervention, Council on Cardiovascular N, Council on Peripheral Vascular D, Council on Quality of C, Outcomes R . Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2012;43:1998\u20132027.","journal-title":"Stroke"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta\u2010analyses: the PRISMA statement","volume":"151","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG; Group P . Preferred reporting items for systematic reviews and meta\u2010analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u2013269, W264.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_11_2","first-page":"541","article-title":"Experience from a multicentre stroke register: a preliminary report","volume":"54","author":"Hatano S","year":"1976","unstructured":"Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541\u2013553.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_1_12_2","unstructured":"Critical appraisal skills programme . CASP cohort study checklist. 2017. Available at: Http:\/\/www.Casp-uk.Net\/casp-tools-checklists. Accessed October 2017."},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/01.STR.25.10.2022","article-title":"Preoperative noninvasive coronary risk stratification in candidates for carotid endarterectomy","volume":"25","author":"Urbinati S","year":"1994","unstructured":"Urbinati S, Di Pasquale G, Andreoli A, Lusa AM, Carini G, Grazi P, Labanti G, Passarelli P, Corbelli C, Pinelli G. Preoperative noninvasive coronary risk stratification in candidates for carotid endarterectomy. Stroke. 1994;25:2022\u20132027.","journal-title":"Stroke"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ane.12291","article-title":"Prediction of myocardial infarction in patients with transient ischaemic attack","volume":"131","author":"Vilanova MB","year":"2015","unstructured":"Vilanova MB, Mauri\u2010Capdevila G, Sanahuja J, Quilez A, Pinol\u2010Ripoll G, Begue R, Gil MI, Codina\u2010Barios MC, Benabdelhak I, Purroy F. Prediction of myocardial infarction in patients with transient ischaemic attack. Acta Neurol Scand. 2015;131:111\u2013119.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2105\/AJPH.47.4_Pt_2.4","article-title":"Coronary heart disease in the Framingham study","volume":"47","author":"Dawber TR","year":"1957","unstructured":"Dawber TR, Moore FE, Mann GV. Coronary heart disease in the Framingham study. Am J Public Health Nations Health. 1957;47:4\u201324.","journal-title":"Am J Public Health Nations Health"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"Stroke prevention by aggressive reduction in cholesterol levels I. high\u2010dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco P","year":"2006","unstructured":"Amarenco P, Bogousslavsky J, Callahan A III, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA. Stroke prevention by aggressive reduction in cholesterol levels I. high\u2010dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549\u2013559.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCULATIONAHA.107.705947","article-title":"How much of the recent decline in the incidence of myocardial infarction in british men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population\u2010based study","volume":"117","author":"Hardoon SL","year":"2008","unstructured":"Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, Morris RW. How much of the recent decline in the incidence of myocardial infarction in british men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population\u2010based study. Circulation. 2008;117:598\u2013604.","journal-title":"Circulation"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/hrt.80.1.40","article-title":"Coronary event and case fatality rates in an English population: results of the oxford myocardial infarction incidence study. The oxford myocardial infarction incidence study group","volume":"80","author":"Volmink JA","year":"1998","unstructured":"Volmink JA, Newton JN, Hicks NR, Sleight P, Fowler GH, Neil HA. Coronary event and case fatality rates in an English population: results of the oxford myocardial infarction incidence study. The oxford myocardial infarction incidence study group. Heart. 1998;80:40\u201344.","journal-title":"Heart"},{"key":"e_1_3_1_19_2","first-page":"CD000197","article-title":"Organised inpatient (stroke unit) care for stroke","volume":"2","author":"Stroke Unit Trialists Collaboration","year":"2002","unstructured":"Stroke Unit Trialists Collaboration . Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2002;2:CD000197.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0140-6736(03)12228-3","article-title":"Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis","volume":"361","author":"Rothwell PM","year":"2003","unstructured":"Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists C . Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361:107\u2013116.","journal-title":"Lancet"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.288.19.2441","article-title":"Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta\u2010analysis","volume":"288","author":"van Walraven C","year":"2002","unstructured":"van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta\u2010analysis. JAMA. 2002;288:2441\u20132448.","journal-title":"JAMA"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1747493015607519","article-title":"Trends in risk of recurrence after the first ischemic stroke in adults younger than 55\u00a0years of age in Sweden","volume":"11","author":"Giang KW","year":"2016","unstructured":"Giang KW, Bjorck L, Stahl CH, Nielsen S, Sandstrom TZ, Jern C, Toren K, Rosengren A. Trends in risk of recurrence after the first ischemic stroke in adults younger than 55\u00a0years of age in Sweden. Int J Stroke. 2016;11:52\u201361.","journal-title":"Int J Stroke"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000083253","article-title":"Trends in five\u2010year survival and risk of recurrent stroke after first\u2010ever stroke in the Perth community stroke study","volume":"19","author":"Hardie K","year":"2005","unstructured":"Hardie K, Jamrozik K, Hankey GJ, Broadhurst RJ, Anderson C. Trends in five\u2010year survival and risk of recurrent stroke after first\u2010ever stroke in the Perth community stroke study. Cerebrovasc Dis. 2005;19:179\u2013185.","journal-title":"Cerebrovasc Dis"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1212\/01.wnl.0000201253.93811.f6","article-title":"Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan study","volume":"66","author":"Dhamoon MS","year":"2006","unstructured":"Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MSV. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan study. Neurology. 2006;66:641\u2013646.","journal-title":"Neurology"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/sim.1461","article-title":"Adjusting for publication bias in the presence of heterogeneity","volume":"22","author":"Terrin N","year":"2003","unstructured":"Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med. 2003;22:2113\u20132126.","journal-title":"Stat Med"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/0470870168.ch15","volume-title":"Publication Bias in Meta\u2010Analysis: Prevention, Assessment and Adjustments","author":"Ioannidis JP","year":"2005","unstructured":"Ioannidis JP. Differentiating biases from genuine heterogeneity: distinguishing artefactual from substantive effects. In: Rothstein HR, Sutton AJ, Borenstein M, eds. Publication Bias in Meta\u2010Analysis: Prevention, Assessment and Adjustments. Sussex: John Wiley & Sons; 2005:287\u2013302."},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1503\/cmaj.060410","article-title":"The appropriateness of asymmetry tests for publication bias in meta\u2010analyses: a large survey","volume":"176","author":"Ioannidis JPA","year":"2007","unstructured":"Ioannidis JPA, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta\u2010analyses: a large survey. CMAJ. 2007;176:1091\u20131096.","journal-title":"CMAJ"},{"key":"e_1_3_1_28_2","unstructured":"The Cochrane Collaboration . Cochrane handbook for systematic reviews of interventions. Available at: www.cochrane.org\/resources\/handbook. Accessed February 8 2007."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta\u2010regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson SG","year":"2002","unstructured":"Thompson SG, Higgins JP. How should meta\u2010regression analyses be undertaken and interpreted? Stat Med. 2002;21:1559\u20131573.","journal-title":"Stat Med"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.117.007267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:38:45Z","timestamp":1760452725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.117.007267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,23]]}},"alternative-id":["10.1161\/JAHA.117.007267"],"URL":"https:\/\/doi.org\/10.1161\/jaha.117.007267","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]},"assertion":[{"value":"2017-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-11-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e007267"}}